https://www.sciforschenonline.org/journals/clinical-cosmetic-dermatology/JCCD145.php In short: A woman with zero T and DHT (Complete Androgen Insensitivity Syndrome) was balding. . The patient received on their bald areas (Figure 1), a Combined Low Laser Light Phototherapy and Growth Factor Hair Formulation Infiltration Therapy (Androgenetic Alopecia Combo Treatment)  consisting of a micro-infiltration session every 3 weeks with non-pharmacological/ hormonal therapy containing a Restructuring Hair Booster-natural Growth Factor Formulation (GFF) industrial product with: Uncross-linked hyaluronic acid Fibroblast growth factors+polypeptide+NaDNA (N-acetyl-2,3- dehydro-2-deoxyneuraminic acid) Amino acids: arginine, alanine, aspartic acid, glutamic acid, glycine, histidine, hydroxyproline, isoleucine, lysine, methionine, phenylalanine, proline, serine, threonine, tyrosine, leucine, valine; Trace elements: Si, Ca, Fe, K, Mg, Mn, Na, P, SE; Vitamins: B12, B9, B3, B5, A, E, B8-Terpenes: ginkgolides A,B,C,M, Bilobalide; Fatty acids: Linoleic acid, Oleic acid Flavonoids: Quercetin, Kaempferol Antioxidants: Vitamin E, Chlorogenic acid, Gallic acid, Quercetin, Kaempferol The micro-infiltration sessions were immediately followed by a 30-minute sessions (2 sessions per month for 24 weeks) of LLLT therapy (LLLT device:-Kernel® KN-7000A) using LED Photodynamic Therapy-Technical data during a single treatment:-Session Time: 20 minutes-Range of emission: 633nm ± 10nm-Power of emission: 80mW/cm2 ± 20%-Type of emission: continue emission. The patient underwent home therapy with industrial topical minoxidil 5% solution, once a day on the front-parietal scalp area. Although it has been assumed that androgenetic alopecia is the result of the abnormal sensitivity of hair follicles of the scalp to circulating androgens, in light of these new data, an alternative potential androgen-independent mechanism for FPHL phenotype deserves to be carefully considered.